Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/29/2000 | EP1054692A2 Antibodies against human cd40 |
11/29/2000 | EP1054689A1 Strategically modified hepatitis b core proteins and their derivatives |
11/29/2000 | EP1054688A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses |
11/29/2000 | EP1054687A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
11/29/2000 | EP1054683A1 Modified heat shock protein-antigenic peptide complex |
11/29/2000 | EP0991770B1 Prostate cancer gene |
11/29/2000 | EP0784753B1 Axial flow valve system in combination with a linera compressor |
11/29/2000 | EP0749323B1 Methods for modulating t cell anergy |
11/29/2000 | EP0629133B1 Peptide-metal ion pharmaceutical applications |
11/29/2000 | EP0555205B1 Dna encoding a growth factor specific for epithelial cells |
11/29/2000 | CN1275164A Neisseria lactoferrin binding protein |
11/29/2000 | CN1275162A Death domain containing receptor 5 |
11/29/2000 | CN1275161A Monoclonal antibody 3-6-A specific to surface of dendritic cells among the peripheral blood leukocytes |
11/29/2000 | CN1275132A Treatmet of obesity |
11/29/2000 | CN1275130A Human gene HSPCO18 (CBCCFE10) |
11/29/2000 | CN1275085A Cytolysis of target cell, reagent and composition for cytolysis and compound for preparing these reagents |
11/29/2000 | CN1275084A Recombinant porcine adenovirus vector |
11/29/2000 | CN1275050A Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity |
11/29/2000 | CN1274729A New tumor necrosin mutein and its preparation and application |
11/29/2000 | CN1274728A New human protein and its code sequence, preparation and application |
11/29/2000 | CN1274727A New human protein and its code sequence, preparation and application |
11/29/2000 | CN1274726A Human tobule related protein 1A/1B light chain 3 and its code sequence, preparation and application |
11/29/2000 | CN1058993C Prepn. and use of molecular chimera for treatment of cancer |
11/29/2000 | CN1058972C Prodn. of human growth hormone by using animal mamma as raw material |
11/28/2000 | US6153814 Polypeptide compositions toxic to lepidopteran insects and methods for making same |
11/28/2000 | US6153741 DNA methylation gene from plants |
11/28/2000 | US6153740 Polynucleotide sequence coding a transport polypeptide; for the treatment of human tumors and viral diseases; antitumor agents |
11/28/2000 | US6153732 Kit for detecting analyte indicative of type II collagen resorption in vivo |
11/28/2000 | US6153730 Detoxification by heparin binding, heparin neutralization, endotoxin binding, endotoxin neutralization or bactericidal activity |
11/28/2000 | US6153729 A polypeptide for drug delivering a variety of therapeutic and diagnostic agents, such as transcription regulatory factors of the cell |
11/28/2000 | US6153728 A protein encoded by an isolated nucleic acid molecule, the complementaray sequence of which hybridizes; producing a specific polyclonal antibodies |
11/28/2000 | US6153600 Administering, in vivo, at or around the site of the solid tumor, a nucleic acid which encodes an ip-10 polypeptide, for inhibiting a solid tumor in a mammal |
11/28/2000 | US6153595 Composition and method for treatment of CMV infections |
11/28/2000 | US6153585 Arylsulfonanilide derivatives |
11/28/2000 | US6153583 OP-3 induced morphogenesis |
11/28/2000 | US6153581 Drug for recovering renal function |
11/28/2000 | US6153580 For generating an immune response in host |
11/28/2000 | US6153579 Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complex |
11/28/2000 | US6153442 Compounds comprise two biotinyl radicals connected by a chain of atoms; the bis-biotin is conjugated to a member of a specific binding pair; for use in an assay for an analyte |
11/28/2000 | US6153435 Nucleotide sequences coding hybrid envelope polypetides; for gene therapy |
11/28/2000 | US6153433 Suppressing microorganismal propagation; insertion of nucleotide sequences coding viricidal polypeptide into cells infected with hepatitis viral agent, monitor for propagation |
11/28/2000 | US6153431 Human immunodeficiency virus co-receptor variants associated with resistance to virus infection |
11/28/2000 | US6153430 Used as indicator of the presence of ovarian cancer tumor cells |
11/28/2000 | US6153429 Cell lines useful for in vitro assay for indentification of carcinogens |
11/28/2000 | US6153423 Nucleotide sequence coding a heart polypeptide; for diagnosis, prevention, and treatment of heart, neuronal, immunological, and tumor defects; antitumor agents |
11/28/2000 | US6153421 Nucleotide sequences which code microorganismal genome; for development of viricides; for preventing mammalian viral infection |
11/28/2000 | US6153409 Simple, efficient method by adding baculovirus vector which codes for protein of interest and green fluorescent protein to insect larvae food, feeding to insect larvae, monitoring for gene expression, harvesting, recovering protein |
11/28/2000 | US6153408 Altered major histocompatibility complex (MHC) determinant and methods of using the determinant |
11/28/2000 | US6153407 Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics |
11/28/2000 | US6153406 Transforming escherichia coli cells with vector coding for protein and selectable marker, culturing in media containing glucose and selection agent, protein is expressed and found in inclusion bodies |
11/28/2000 | US6153405 Nucleic acid which encodes a leader sequence from nisin and/or subtilin and a lantibiotic; for recombinant production of antibiotics |
11/28/2000 | US6153404 Regulatory sequence linked to sequence coding for a heterologous polypeptide; for controlled/inducible gene expression in recombinant system |
11/28/2000 | US6153403 Lysosomal-associated multispanning membrane protein, LAPTM5 and nucleic acid encoding LAPTM5 |
11/28/2000 | US6153402 Death domain containing receptors |
11/28/2000 | US6153395 ICAM-related protein |
11/28/2000 | US6153391 Contacting p53 and oncoprotein with a peptide fragment or analogue including a defined amino acid sequence or an organic molecule having three-dimensional structure of that amino acid sequence; interferes with binding |
11/28/2000 | US6153390 Isolated antigenic polypeptide from helicobacter pylori; for immunoassay diagnosis |
11/28/2000 | US6153382 Viral growth inhibition |
11/28/2000 | US6153380 In vitro mehtod by introducing library of random nucleic acids into cells to produce peptides, screening for cells exhibiting an altered phenotype; better intracellular localization of peptides |
11/28/2000 | US6153378 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus |
11/28/2000 | US6153377 Synthetic DNA derived recombinant HIV antigens |
11/28/2000 | US6153201 Oral immunization with papillomavirus virus-like particles |
11/28/2000 | US6153200 Administering an isolated and purified bacterial dnajp1 peptide having the amino acid sequence |
11/28/2000 | US6153199 Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus |
11/28/2000 | US6153195 Method of delivering drugs to cells specific for an HL-60 lectin |
11/28/2000 | US6153194 Borrelia burgdorferi outer membrane proteins |
11/28/2000 | US6153192 An amino acid sequence consisting of at least 6 contiguous amino acids and no more than 39 contiguous amino acids found at positions 144-183 of human microglobulin; for use in immunoassay to determine human microglobulin in a sample |
11/28/2000 | US6153191 Giardia treatment and antibody |
11/28/2000 | US6153190 Monoclonal antibodies which are receptor agonists; use as the immunizing antigen |
11/28/2000 | US6153189 Human TRK receptors and neurotrophic factor inhibitors |
11/28/2000 | US6153186 Red blood cells loaded with S-nitrosothiol and uses therefor |
11/28/2000 | US6153183 A modified human interleukin-3 polypeptide, comprises the replacement of 6 to about 44 residues at positions 17-118 of native interleukin-3 by other amino acids with the proviso that asparagine at position 101 and lysine at position 116 |
11/28/2000 | US6153182 Lymphotactin as an adjuvant |
11/28/2000 | US6152358 Bioluminescent novelty items |
11/28/2000 | CA2308259A1 Method for assaying the function of flaa1 and wbpm |
11/28/2000 | CA2305716A1 Method for assay of wbpm |
11/28/2000 | CA2182970C Lyophilized stem cell factor formulations |
11/28/2000 | CA2137348C Synthetic peptide lung surfactants having covalently bonded antioxidants |
11/28/2000 | CA2074681C Genetic engineering process for the production of s-(+)-2,2-dimethylcyclopropanecarboxamide by microorganisms |
11/28/2000 | CA2066428C Structural alterations of the egf receptor gene in human gliomas |
11/28/2000 | CA2032253C 5-lipoxygenase activating protein |
11/27/2000 | CA2310218A1 A composition and method for treating bacterial infection |
11/23/2000 | WO2000070665A2 Long lasting anti-angiogenic peptides |
11/23/2000 | WO2000070351A2 Protein-protein interactions and methods for identifying them |
11/23/2000 | WO2000070091A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN PROTEIN KINASE C-δ EXPRESSION |
11/23/2000 | WO2000070089A1 Cdx2 is downstream mediator of apc tumor suppressor activity |
11/23/2000 | WO2000070077A2 POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES ENCODING MURINE ORGANIC ANION TRANSPORTER 5 (mOATP5) AND SCREENING METHODS THEREOF |
11/23/2000 | WO2000070076A1 Tm4sf receptors |
11/23/2000 | WO2000070075A1 STREPTOCOCCUS PNEUMONIAE yerS |
11/23/2000 | WO2000070071A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35 |
11/23/2000 | WO2000070069A1 Acquired resistance genes in plants |
11/23/2000 | WO2000070066A1 The maize rs324 promoter and methods for use thereof |
11/23/2000 | WO2000070061A2 Senescence-related promoters |
11/23/2000 | WO2000070059A2 Signal transduction genes and methods of use |
11/23/2000 | WO2000070055A1 Rnp originating in paramyxovirus |
11/23/2000 | WO2000070054A1 Pathogen-resistant grape plants |
11/23/2000 | WO2000070053A1 Transgenic plants exhibiting an altered flowering time |
11/23/2000 | WO2000070052A1 Gene isolated from ricinus communis encoding a new protein that interacts with the oleate 12-hydroxylase enzyme |
11/23/2000 | WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY |
11/23/2000 | WO2000070050A1 Compositions and methods for the treatment of immune related diseases |